Catalog No.:AA01EOPE

308362-25-6 | Ridinilazole

Name: Name:Ridinilazole
Brand: AABLOCKS
SKU: AA01EOPE
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

100mg

98%

in stock

$238.00 $167.00

- +

98%

in stock

$817.00 $572.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA01EOPE

Chemical Name:

Ridinilazole

CAS Number:

308362-25-6

Molecular Formula:

C24H16N6

Molecular Weight:

388.4240

MDL Number:

MFCD28963972

SMILES:

n1ccc(cc1)c1[nH]c2c(n1)cc(cc2)c1ccc2c(c1)nc([nH]2)c1ccncc1

Properties

Computed Properties

Complexity:

524

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

3.9

Downstream Synthesis Route

308362-25-6

1263416-32-5

2416603-94-4

[1]Singh,Jatinder;Kim,DongHwan;Kim,Eun-Hee;Kim,Hyunuk;Hadiputra,Rizky;Jung,Jaehoon;Chi,Ki-Whan[JournaloftheAmericanChemicalSociety,2020,vol.142,#20,p.9327-9336]

308362-25-6

2852147-48-7

2416603-92-2

[1]Singh,Jatinder;Kim,DongHwan;Kim,Eun-Hee;Kim,Hyunuk;Hadiputra,Rizky;Jung,Jaehoon;Chi,Ki-Whan[JournaloftheAmericanChemicalSociety,2020,vol.142,#20,p.9327-9336]

91-95-2

35451-46-8

308362-25-6

[1]CurrentPatentAssignee:SUMMITTHERAPEUTICSPLC-WO2021/9514,2021,A1Locationinpatent:Page/Pagecolumn54;55

100-48-1

91-95-2

308362-25-6

[1]CurrentPatentAssignee:SUMMITTHERAPEUTICSPLC-WO2022/153056,2022,A1Locationinpatent:Page/Pagecolumn65-66;75

[2]CurrentPatentAssignee:SUMMITTHERAPEUTICSPLC-WO2022/153246,2022,A1Locationinpatent:Paragraph00329;00330

Literature

Title: Vickers RJ, et al. Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents. 2016 Aug;48(2):137-43.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS

Related Products of 308362-25-6

64263-00-9

84123-77-3

1354958-14-7

Building Blocks

More >

1869980-05-1 | (1-butyl-6-methoxy-1H-indol-3-yl)-1-naphthalenyl-methanone | AA01EOXU

869577-51-5 | N-[4-[4-[(2-oxiranylmethyl)sulfonyl]phenoxy]phenyl]-methanesulfonamide | AA01EP7Y | MFCD24369005

122882-90-0 | N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-pentanamide | AA01EPGB

526191-19-5 | 5-oxo-5-[phenyl[1-(2-phenylethyl)-4-piperidinyl]amino]-pentanoicacid | AA01EPLI

1420071-13-1 | 1-[2-[[(cyclopropylcarbonyl)ethylamino]methyl]-4-(trifluoromethyl)phenyl]-6-methyl-1H-pyrrolo[2,3-b]pyridine-3-aceticacid | AA01EPS8

2121543-66-4 | 25-[[1-(3α)-cholest-5-en-3-yl-1H-1,2,3-triazol-4-yl]methoxy]-26,27,28-trihydroxy-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17-triaceticacid,trisodiumsalt | AA01EQ1B

2055172-61-5 | (4-[1,1'-biphenyl]-4-yl-1H-1,2,3-triazol-1-yl)[(2S)-2-(phenylmethyl)-1-piperidinyl]-methanone | AA01EQ8F

931314-31-7 | SPA70-LC-1|SpecificPXRantagonist70 | AA01EQD9 | MFCD14774311

1208077-27-3 | 1-Bromo-3,4-difluoro-2-iodobenzene | AA01EQWP | MFCD12922588

1349718-38-2 | 1-(4-(Hydrazinylmethyl)piperidin-1-yl)ethanone dihydrochloride | AA01ESAI | MFCD20233296

Tags:308362-25-6 Molecular Formula|308362-25-6 MDL|308362-25-6 SMILES|308362-25-6 Ridinilazole